These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 17242640)

  • 1. [Cutaneous effects related to the use of tyrosine kinase inhibitors].
    Mateus C
    Rev Pneumol Clin; 2007 Jan; 63(1 Pt 2):2S16-7. PubMed ID: 17242640
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous side-effects of EGFR inhibitors and their management.
    Ehmann LM; Ruzicka T; Wollenberg A
    Skin Therapy Lett; 2011 Jan; 16(1):1-3. PubMed ID: 21293833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fulminant acneiform eruptions after administration of dovitinib in a patient with renal cell carcinoma.
    Hsiao YW; Lin YC; Hui RC; Yang CH
    J Clin Oncol; 2011 Apr; 29(12):e340-1. PubMed ID: 21263088
    [No Abstract]   [Full Text] [Related]  

  • 4. Facial acneiform rash associated with sorafenib.
    Fleta-Asín B; Vañó-Galván S; Ledo-Rodríguez A; Truchuelo-Díez M; Jaén-Olasolo P
    Dermatol Online J; 2009 Apr; 15(4):7. PubMed ID: 19450400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infliximab-induced acne: a new case and review of published reports.
    Steels E; Peretz A; Vereecken P
    J Dermatolog Treat; 2009; 20(1):59-60. PubMed ID: 18608731
    [No Abstract]   [Full Text] [Related]  

  • 6. Classification and management of skin, hair, nail and mucosal side-effects of epidermal growth factor receptor (EGFR) inhibitors.
    Galimont-Collen AF; Vos LE; Lavrijsen AP; Ouwerkerk J; Gelderblom H
    Eur J Cancer; 2007 Mar; 43(5):845-51. PubMed ID: 17289377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choosing between isotretinoin and acitretin for epidermal growth factor receptor inhibitor and small molecule tyrosine kinase inhibitor acneiform eruptions.
    Costello CM; Hill HE; Brumfiel CM; Yang YW; Swanson DL
    J Am Acad Dermatol; 2021 Mar; 84(3):840-841. PubMed ID: 33039483
    [No Abstract]   [Full Text] [Related]  

  • 8. A comedonal acneiform eruption following dovitinib therapy.
    Gracia-Cazaña T; Pastushenko I; Concellón MA; Grasa-Jordán MP
    Clin Exp Dermatol; 2014 Oct; 39(7):842-3. PubMed ID: 25196373
    [No Abstract]   [Full Text] [Related]  

  • 9. A retrospective chart review on oral retinoids as a treatment for epidermal growth factor receptor inhibitor- and mitogen-activated protein kinase kinase inhibitor-induced acneiform eruptions.
    Andrews ED; Garg N; Patel AB
    J Am Acad Dermatol; 2020 Apr; 82(4):998-1000. PubMed ID: 31604105
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of acne fulminans successfully treated with cyclosporin a and prednisolone.
    Tago O; Nagai Y; Matsushima Y; Ishikawa O
    Acta Derm Venereol; 2011 May; 91(3):337-8. PubMed ID: 21369677
    [No Abstract]   [Full Text] [Related]  

  • 11. Survey of Oncologists and Dermatologists in Canada on the Management of Acneiform Eruptions Induced by Epidermal Growth Factor Receptor Inhibitors.
    Bierbrier R; Esfahani K; Pehr K
    J Cutan Med Surg; 2022; 26(6):624-625. PubMed ID: 35980317
    [No Abstract]   [Full Text] [Related]  

  • 12. Cronkhite Canada syndrome.
    Sood A; Sood N; Midha V
    J Assoc Physicians India; 2000 Nov; 48(11):1116-8. PubMed ID: 11310396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermatological adverse reactions to cancer chemotherapy.
    Pavey RA; Kambil SM; Bhat RM
    Indian J Dermatol Venereol Leprol; 2015; 81(4):434. PubMed ID: 26144855
    [No Abstract]   [Full Text] [Related]  

  • 14. A distinct cutaneous reaction to sorafenib and a multikinase inhibitor.
    Joncas V; Sammour R; Krasny M; Bouffard D; Provost N
    Int J Dermatol; 2008 Jul; 47(7):767-9. PubMed ID: 18613894
    [No Abstract]   [Full Text] [Related]  

  • 15. Sirolimus-induced inflammatory papules with acquired reactive perforating collagenosis.
    Lübbe J; Sorg O; Malé PJ; Saurat JH; Masouyé I
    Dermatology; 2008; 216(3):239-42. PubMed ID: 18182818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of a child with MEK inhibitor-induced acneiform eruption with low-dose isotretinoin.
    Gupta R; Craddock MF
    Pediatr Dermatol; 2022 Jul; 39(4):646-647. PubMed ID: 35896172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escalating therapy of cutaneous side effects of EGFR inhibitors: experience of German reference centers.
    Homey B; Gerber PA; Wollenberg A; Dirschka T; Hassel JC; Bölke E; Hauschild A; Gutzmer R
    J Dtsch Dermatol Ges; 2012 Aug; 10(8):559-63. PubMed ID: 22672156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of topical epidermal growth factor cream for patients with epidermal growth factor receptor inhibitor-induced acneiform eruption: a randomized controlled trial.
    Lee JH; Ju HJ; Kwon HS; Jung HM; Kim GM; Bae JM; An HJ
    Br J Dermatol; 2020 Jan; 182(1):219-221. PubMed ID: 31301244
    [No Abstract]   [Full Text] [Related]  

  • 19. Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy.
    Rzepecki AK; Cheng H; McLellan BN
    J Am Acad Dermatol; 2018 Sep; 79(3):545-555. PubMed ID: 29733938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in Management Between Dermatologists and Oncologists for Acneiform Eruptions in Patients on Monoclonal Antibody Epidermal Growth Factor Receptor Inhibitors.
    Oliel S; Bierbrier R; D'Aguanno K; Esfahani K; Pehr K
    J Cutan Med Surg; 2024; 28(1):79-81. PubMed ID: 38156654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.